Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Study proves effectiveness of Pulmicort
February 24th, 2005
New results from the START study have been published in the Annals of Allergy, Asthma and Immunology, revealing 3-year safety outcome data for Pulmicort (budesonide). These data further reinforce previous findings that Pulmicort in low doses is well tolerated in long term treatment of asthma in both adults and children. Patients enlisted in the START study, the largest ever controlled asthma trial involving more than 7,000 patients in 32 different countries, were aged from 5-66 years and randomized to receive either Pulmicort or placebo once daily in addition to their usual asthma therapy. Pulmicort was taken viaTurbuhaler...
Source: Women's Health Weekly (2005-02-24)
|
